Literature DB >> 16695602

A STUDY OF ANTIFIBRINOLYSIN ACTIVITY IN THE PLASMAS OF VARIOUS ANIMAL SPECIES.

M M Guest1, B M Daly, A G Ware, W H Seegers.   

Abstract

Year:  1948        PMID： 16695602      PMCID： PMC439556          DOI： 10.1172/JCI102029

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

Authors:  W S Tillett
Journal:  Bacteriol Rev       Date:  1938-12

2.  STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. II. THE INHIBITION OF STREPTOCOCCAL FIBRINOLYSIS BY ANTIFIBRINOLYSIN AND ANTIPROTEASE.

Authors:  M H Kaplan
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

3.  Nomenclature of Parenteral Proteases.

Authors:  J H Ferguson
Journal:  Science       Date:  1947-05-09       Impact factor: 47.728
  3 in total
  10 in total

1.  Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject.

Authors:  M M GUEST
Journal:  J Clin Invest       Date:  1954-11       Impact factor: 14.808

2.  A STUDY OF THE ANTIFIBRINOLYSIN ACTIVITY IN HUMAN PLASMAS DURING PATHOLOGICAL STATES.

Authors:  M M Guest; B M Daly; A G Ware; W H Seegers
Journal:  J Clin Invest       Date:  1948-11       Impact factor: 14.808

3.  Studies on a proteolytic enzyme system of the blood. I. Inhibition of fibrinolysin.

Authors:  J H LEWIS; J H FERGUSON
Journal:  J Clin Invest       Date:  1950-04       Impact factor: 14.808

4.  Congenital dysfibrinogenemia: fibrinogen Detroit.

Authors:  E F Mammen; A S Prasad; M I Barnhart; C C Au
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

5.  Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinctive properties and the specificity of their action.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1952-06       Impact factor: 14.307

6.  The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase).

Authors:  A J JOHNSON; W S TILLETT
Journal:  J Exp Med       Date:  1952-05-01       Impact factor: 14.307

7.  Studies on the activation of serum protease by an antigen-antibody system.

Authors:  J V JEMSKI; J A FLICK; W R STINEBRING
Journal:  J Exp Med       Date:  1953-03       Impact factor: 14.307

8.  Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

9.  Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum.

Authors:  P S NORMAN
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307

10.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.